Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myelomaJames R. Berenson, Robert Vescio, Honghao Yang et al.|British Journal of Haematology|2022Cited by 12
Ruxolitinib and Methylprednisolone for Treatment of Patients with Relapsed/Refractory Multiple MyelomaJames R. Berenson, Robert Vescio, Daisy Martinez et al.|Blood|2022Cited by 2